Rain Oncology Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2020 to 2022

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Rain Oncology Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2020 to 2022.
  • Rain Oncology Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2023 was -$7.03M, a 61% increase year-over-year.
  • Rain Oncology Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2023 was -$72.3M, a 1.73% decline year-over-year.
  • Rain Oncology Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$75.7M, a 47.3% decline from 2021.
  • Rain Oncology Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$51.4M, a 144% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$75.7M -$24.3M -47.3% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-09
2021 -$51.4M -$30.3M -144% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-09
2020 -$21.1M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.